Stock Events

Stock Events

Euglena 

€1.9000
0
+€0.02+1.06% Friday 15:17

Statistics

Day High
1.93
Day Low
1.89
52W High
1.93
52W Low
1.89
Volume
-
Avg. Volume
-
Mkt Cap
265.09M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

16NovExpected
Q2 2026
Next
0
0.34
0.67
1
Expected EPS
N/A
Actual EPS
N/A

Financials

-1.63%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
285.12MRevenue
-4.63MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 8EG.STU. It's not an investment recommendation.
NTT
3
9432.TSE
Orix
2
8591.TSE
SoftBank Group
2
9984.TSE
Aeon.
2
8267.TSE

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pond Technologies
POND.V
Mkt Cap855,922
Pond Technologies focuses on algae production for nutraceuticals and bio-products, directly competing with Euglena's core business of microalgae products.
Cyanotech
CYAN
Mkt Cap3.84M
Cyanotech Corporation specializes in the production of microalgae for nutritional supplements, competing in the same market as Euglena.
Basf
BASFY
Mkt Cap47.72B
BASF SE operates in the chemicals sector, including bioactive ingredients and health products, making it a competitor in Euglena's market for sustainable and health-related products.
Archer Daniels Midland
ADM
Mkt Cap39.3B
Archer Daniels Midland Company is a global leader in bioenergy and food ingredients, competing with Euglena in the bio-products and nutrition sectors.
CarGurus
CARG
Mkt Cap3.26B
Cargill, Incorporated provides food, agriculture, financial, and industrial products and services, including bio-industrial innovations, competing with Euglena's sustainability and nutrition initiatives.

About

Euglena Co., Ltd. is a Japanese enterprise specializing in the research, development, cultivation, and marketing of microalgae. Its operations are structured around two primary divisions: Healthcare Business and Energy/Environment Business. The company manufactures and sells a variety of euglena-derived food items and cosmetics. Additionally, it offers a broad portfolio of consumer goods, such as health foods, beverages, confectionery, and sports nutrition products. Furthermore, Euglena is engaged in pioneering biofuel and environmental technologies leveraging microalgae, and it makes strategic investments in the biotechnology sector. Its merchandise is distributed through numerous retail channels, including convenience stores, pharmacies, grocery stores, beauty parlors, and various specialty retailers. The company was established in Tokyo, Japan, in 2005.
Show more...
CEO
Employees
793
Country
Japan
ISIN
JP3944370000
WKN
000A1KCNK

Listings

STU
DE
8EG.STU
MU
DE
8EG.MU
OTC Link
US
EGLNF
TSE
JP
2931.TSE

0 Comments

Share your thoughts

FAQ

What is Euglena stock price today?▼
The current price of 8EG.STU is €1.90 EUR — it has increased by +1.06% in the past 24 hours. Watch Euglena stock price performance more closely on the chart.
What is Euglena stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Euglena stocks are traded under the ticker 8EG.STU.
What is Euglena market cap?▼
Today Euglena has the market capitalization of 265.09M
When is the next Euglena earnings date?▼
Euglena is going to release the next earnings report on November 16, 2026.
What were Euglena earnings last quarter?▼
8EG.STU earnings for the last quarter are 0 EUR per share, whereas the estimation was N/A EUR resulting in a N/A surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Euglena revenue for the last year?▼
Euglena revenue for the last year amounts to 285.12M EUR.
What is Euglena net income for the last year?▼
8EG.STU net income for the last year is -4.63M EUR.
How many employees does Euglena have?▼
As of September 05, 2026, the company has 793 employees.
In which sector is Euglena located?▼
Euglena operates in the Other sector.
When did Euglena complete a stock split?▼
The last stock split for Euglena was on September 26, 2013 with a ratio of 5:1.